Skip to main content
Back to EIC Accelerator

EIC Accelerator's Biopharma Portfolio

Browse 11 Biopharma companies funded by EIC Accelerator. See funding amounts, founder contacts, and investment details.

Biopharma Companies
11
Total Funding in Biopharma
$83.2M

Biopharma Portfolio Companies (11)

Export
BiopharmaBiotechnologyHealth CareMedical

Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research.

Marseille, France
September 2025
$14.1M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife Science

NIMBLE Diagnostics offers a range of paternity, family relationship, and ancestry DNA testing services.

Barcelona, Spain
August 2024
Non-equity Assistance

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

DIANA Biotechnologies specializes in the development of products based on research in clinical diagnostics and drug discovery areas.

Vestec, Czech Republic
April 2026
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyManufacturing

Solmeyea produces single-cell proteins from CO2 for food applications, aiming at CO2 circularity and addressing climate issues.

Pallíni, Greece
April 2025
$3.3M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.

Wroclaw, Poland
March 2026
$17.7M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Transforming chronic wound care with breakthrough enzymatic technology

Cambridge, United Kingdom
March 2024
$518K
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

AptaTargets is a biopharmaceutical company focused in developing therapeutic

Madrid, Spain
February 2024
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Invitris is a biotech company that develops protein-based drugs.

Garching Bei Múnchen, Germany
February 2025
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsMedicalPharmaceuticalTherapeutics

Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.

Reykjavík, Iceland
January 2025
$27.5M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyOncologyPharmaceutical

ErVimmune develops cancer vaccines and T cell therapies targeting cold tumors using AI-driven antigen discovery.

Lyon, France
January 2026
$19.9M
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaLife Science

Scienta Lab is an AI-powered platform pioneering Precision Immunology

Paris, France
July 2025
Seed

Founder Contacts

30,000+ verified contacts

Explore EIC Accelerator's Full Portfolio

View all companies funded by EIC Accelerator across every industry and funding stage.

View Full EIC Accelerator Portfolio